유방암에서 Claudin-1과 ZO-1 단백 발현 감소와 임상-병리학적 인자와의 연관성

다국어 초록 (Multilingual Abstract)

Purpose: Tight junction proteins are either over-expressed or suppressed in some cancers. These suppressions of claudin-1 and ZO-1 protein are known to have a significant relationship with the progression of breast cancer. The authors reviewed 42 cases of breast cancer and the staining status of claudin-1 and ZO-1 in order to evaluate Claudin-1 and ZO-1 as clinicopathologic risk factors.
Methods: Immunohistological staining for Claudin-1 and ZO-1 was performed in 42 post-operative pathologically diagnosed infiltrating duct carcinoma specimens. The rate of expression was compared with the clinical record, the pathological diagnosis, the estrogen receptor and progesteron receptor status and the c-erbB2 gene to evaluate the protein expression-breast cancer progression relationship and to investigate the expressions of Claudin-1 and ZO-1 as a prognostic factors in breast cancer.
Results: The claudin-1 and ZO-1 expressions were both decreased in all the post-operative specimens. The claudin-1 expressions were significantly decreased 100%, 82.4% and 66.7% as the histologic grade increased. The ZO-1 expressions were shown in 44.8% of the lymph node metastasis negative group and in 7.7% of the lymph node positive group. The expression of ZO-1 decreased by 53.3%, 28.6% and 0%, with statistical significance, as the stage increased.
Conclusion: The claudin-1 expressions were decreased in the poorly differentiated group, i.e., a high histologic grade, and the ZO-1 expressions were decreased in the lymph node positive group and in the high stage cancer. This shows the possibility of Claudin-1 and ZO-1 as factors for tumorigenesis and progression and as prognostic factors in breast cancer.

목차 (Table of Contents)

• 서론
• 방법
• 결과
• 고찰
• 결론
• REFERENCES

참고문헌 (Reference)

1 정유경, "대장의 샘종 및 샘암종에서 Osteopontin, ZO-1 및 E-cadherin의 발현" 대한병리학회 39 (39): 242-250, 2005

2 Ren J, "Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary crcinoma" 50 : 358-362, 1990

3 Martin TA, "Tight junctions and their role in cancer metastasis" 16 : 1183-1195, 2001

4 Gonzalez-Mariscal L, "Tight junction proteins" 81 : 1-44, 2003

5 Willott E, "The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions" 90 : 7834-7838, 2003

6 Balda MS, "The tight junction protein ZO-1 and an interacting transcription factor regulate erb-2 expression" 19 : 2024-2033, 2000

7 Gonzalez-Mariscal L, "The relationship between structure and function of tight junctions, In Tight Junctions. 2nd ed" CRC Press 89-110, 2001

8 Tokés AM, "The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors" 201 : 537-544, 2005

9 Kawabe H, "Pilt: a novel peripheral membrane protein at tight junctions in epithelial cells" 276 : 48350-48355, 2001

10 Mitic LL, "Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins" 279 : 250-254, 2000

11 Kominsky SL, "Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast" 22 : 2021-2033, 2003

12 Hoover KB, "Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity" 153 : 1767-1773, 1998

13 Hough CD, "Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer" 60 : 6281-6287, 2000

14 Sobel G, "Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma" 35 : 162-169, 2005

15 Kramer F, "Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer" 107 : 249-256, 2000

16 Vazquez-Oritz G, "Gene identification by cDNA arrays in HPV-positive cervical cancer" 36 : 448-458, 2005

17 Sato N, "Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas" 164 : 903-914, 2004

18 Kimura Y, "Expression of occludin tight junction associated protein in human digestive tract" 151 : 45-54, 1997

19 Sioni Y., "Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma" 35 : 1531-1536, 2004

20 Tokés AM, "Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study" 7 : 296-305, 2005

21 Resnick MB, "Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study" 18 : 511-518, 2005

22 Gyorffy H, "Claudin expression in Barrett's esophagus and adenocarcinoma" 447 : 961-968, 2005

23 Furuse M, "Claudin based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice" 156 : 1099-1111, 2002